Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Psychoneuroendocrinology|August 19, 1999
Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjectsG Laakmann, C Schüle, T Baghai, et al.
Neuropsychobiology|February 28, 2003
Influence of mirtazapine on salivary cortisol in depressed patientsG Laakmann, J Hennig, T Baghai, et al.
Neuropsychobiology|February 26, 2004
Endocrinological effects of high-dose Hypericum perforatum extract WS 5570 in healthy subjectsC Schüle, T Baghai, N Sauer, et al.
Psychopharmacology|January 1, 1984
Comparison of growth hormone and prolactin stimulation induced by chlorimipramine and desimipramine in man in connection with chlorimipramine metabolismG Laakmann, M Gugath, H J Kuss, et al.
Psychoneuroendocrinology|January 1, 1985
Dose-dependent growth hormone, prolactin and cortisol stimulation after i.v. administration of desimipramine in human subjectsG Laakmann, H W Schoen, D Blaschke, et al.
Pharmacopsychiatry|May 1, 1988
Double-blind randomized trial of the benzodiazepine derivative metaclazepam as compared with placebo treatment of outpatients with anxiety syndromesG Laakmann, D Blaschke, H Hippius, et al.
Pharmacopsychiatry|August 24, 2001
Neuroendocrine effects of Hypericum extract WS 5570 in 12 healthy male volunteersC Schüle, T Baghai, A Ferrera, et al.
Pharmacopsychiatry|May 1, 1989
Double-blind study of metaclazepam versus diazepam treatment of outpatients with anxiety syndromeG Laakmann, D Blaschke, H Hippius, et al.
Pharmacopsychiatry|July 31, 1998
St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacyG Laakmann, C Schüle, T Baghai, et al.
Arzneimittel-Forschung|January 1, 1978
[Influence of single and repeated administration of desipramine (DMI) on the secretion of growth hormone (GH) (author's transl)]G Laakmann, O Benkert, E Neulinger, et al.
Pageof 4